Lumibird SA - Asset Resilience Ratio

Latest as of June 2025: 22.85%

Lumibird SA (LBIRD) has an Asset Resilience Ratio of 22.85% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Lumibird SA for a breakdown of total debt and financial obligations.

Liquid Assets

€99.62 Million

≈ $116.47 Million USD Cash + Short-term Investments

Total Assets

€435.94 Million

≈ $509.66 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Lumibird SA's Asset Resilience Ratio has changed over time. See Lumibird SA net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Lumibird SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lumibird SA market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€45.19 Million	10.37%
Short-term Investments	€54.43 Million	12.49%
Total Liquid Assets	€99.62 Million	22.85%

Asset Resilience Insights

Good Liquidity Position: Lumibird SA maintains a healthy 22.85% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Lumibird SA Industry Peers by Asset Resilience Ratio

Compare Lumibird SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	57.28%
Leveljump Healthcare Corp V:JUMP	Diagnostics & Research	32.45%
Berry Genomics Co Ltd SHE:000710	Diagnostics & Research	0.45%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Lumibird SA (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Lumibird SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	12.73%	€54.71 Million ≈ $63.97 Million	€429.80 Million ≈ $502.48 Million	+4.81pp
2023-12-31	7.92%	€32.08 Million ≈ $37.51 Million	€405.25 Million ≈ $473.78 Million	+1.13pp
2022-12-31	6.79%	€25.26 Million ≈ $29.53 Million	€372.04 Million ≈ $434.96 Million	+6.07pp
2021-12-31	0.72%	€2.50 Million ≈ $2.93 Million	€347.62 Million ≈ $406.41 Million	+38.87pp
2020-12-31	-38.15%	€-116.51 Million ≈ $-136.22 Million	€305.43 Million ≈ $357.08 Million	-38.16pp
2019-12-31	0.02%	€30.00K ≈ $35.07K	€193.76 Million ≈ $226.52 Million	-0.02pp
2018-12-31	0.04%	€53.00K ≈ $61.96K	€151.03 Million ≈ $176.58 Million	-14.26pp
2017-12-31	14.30%	€17.31 Million ≈ $20.24 Million	€121.08 Million ≈ $141.55 Million	+10.51pp
2016-12-31	3.79%	€2.32 Million ≈ $2.71 Million	€61.19 Million ≈ $71.54 Million	+13.41pp
2015-12-31	-9.63%	€-5.88 Million ≈ $-6.88 Million	€61.11 Million ≈ $71.44 Million	-11.23pp
2013-12-31	1.60%	€825.00K ≈ $964.51K	€51.49 Million ≈ $60.20 Million	+0.06pp
2012-12-31	1.54%	€814.00K ≈ $951.65K	€52.71 Million ≈ $61.62 Million	+0.45pp
2011-12-31	1.09%	€637.00K ≈ $744.72K	€58.29 Million ≈ $68.15 Million	+0.09pp
2010-12-31	1.01%	€557.00K ≈ $651.19K	€55.28 Million ≈ $64.63 Million	+0.16pp
2009-12-31	0.85%	€463.00K ≈ $541.30K	€54.77 Million ≈ $64.03 Million	+0.02pp
2007-12-31	0.82%	€572.00K ≈ $668.73K	€69.41 Million ≈ $81.14 Million	+0.15pp
2006-12-31	0.67%	€372.00K ≈ $434.91K	€55.22 Million ≈ $64.56 Million	-0.04pp
2005-12-31	0.72%	€314.00K ≈ $367.10K	€43.91 Million ≈ $51.34 Million	+0.17pp
2004-12-31	0.54%	€147.00K ≈ $171.86K	€27.20 Million ≈ $31.80 Million	-0.59pp
2003-12-31	1.13%	€317.00K ≈ $370.61K	€28.16 Million ≈ $32.92 Million	+0.91pp
2002-12-31	0.22%	€69.00K ≈ $80.67K	€31.96 Million ≈ $37.37 Million	+0.12pp
2001-12-31	0.09%	€31.00K ≈ $36.24K	€33.26 Million ≈ $38.88 Million	-0.02pp
2000-12-31	0.12%	€206.00K ≈ $240.84K	€175.71 Million ≈ $205.42 Million	--

pp = percentage points

About Lumibird SA

PA:LBIRD France Diagnostics & Research

Market Cap

$553.53 Million

€473.46 Million EUR

Market Cap Rank

#12406 Global

#186 in France

Share Price

€21.50

Change (1 day)

+2.87%

52-Week Range

€11.45 - €25.10

All Time High

€25.10